AstraZeneca, $AZN, to spend $50-billion to expand manufacturing, research capabilities in U.S.
From X
Disclaimer: The above content reflects only the author's opinion and does not represent any stance of CoinNX, nor does it constitute any investment advice related to CoinNX.